Background: Osteochondral allografts are currently stored at 4°C for 2 to 6 weeks before implantation. At 4°C, chondrocyte viability, especially in the superficial zone, deteriorates starting at 2 weeks. Alternative storage conditions could maintain chondrocyte viability beyond 2 weeks, and thereby facilitate increased graft availability and enhanced graft quality.
Purpose: The objective of the study was to determine the effects of prolonged 37°C storage compared with traditional 4°C storage on chondrocyte viability and cartilage matrix content.
Study Design: Controlled laboratory study.
Methods: Osteochondral samples from humeral heads of adult goats were analyzed (i) fresh, or after storage in medium for (ii) 14 days at 4°C including 10% fetal bovine serum, (iii) 28 days at 4°C including 10% fetal bovine serum, (iv) 28 days at 37°C without fetal bovine serum, (v) 28 days at 37°C including 2% fetal bovine serum, or (vi) 28 days at 37°C including 10% fetal bovine serum. Portions of samples were analyzed by microscopy after LIVE/DEAD staining to determine chondrocyte viability and density, both en face (to visualize the articular surface) and vertically (overall and in superficial, middle, and deep zones). The remaining cartilage was analyzed for sulfated glycosaminoglycan and collagen.
Results: The 37°C storage maintained high chondrocyte viability compared with 4°C storage. Viability of samples after 28 days at 37°C was ˜80% at the cartilage surface en face, ˜65% in the superficial zone, and ˜70% in the middle zone, which was much higher than ˜45%, ˜20%, and ˜35%, respectively, in 4°C samples after 28 days, and slightly decreased from ˜100%, ˜85%, and ˜95%, respectively, in fresh controls. Cartilage thickness, glycosaminoglycan content, and collagen content were maintained for 37°C and 4°C samples compared with fresh controls.
Conclusion: The 37°C storage of osteochondral grafts supports long-term chondrocyte viability, especially at the vulnerable surface and superficial zone of cartilage.
Clinical Relevance: Storage of allografts at a physiologic temperature of 37°C may prolong storage duration, improve graft availability, and improve treatment outcomes.
2. Aydelotte MB, Kuettner KE. Differences between sub-populations of cultured bovine articular chondrocytes: I. Morphology and cartilage matrix production.Connect Tissue Res.1988;18:205–222.
3.
3. Bae WC, Schumacher BL, Sah RL. Indentation probing of human articular cartilage: effect on chondrocyte viability.Osteoarthritis Cartilage.2007;15:9–18.
4.
4. Ball ST, Amiel D, Williams SK, et al. The effects of storage media on fresh human osteochondral allografts.Clin Orthop Relat Res.2004;418:246–252.
5.
5. Beaver RJ, Mahomed M, Backstein D, Davis A, Zukor DJ, Gross AE. Fresh osteochondral allografts for post-traumatic defects in the knee.J Bone Joint Surg Br.1992;74:105–110.
6.
6. Bian L, Lima EG, Angione SL, et al. Mechanical and biochemical characterization of cartilage explants in serum-free culture.J Bio-mech.2008;41(6):1153–1159.
7.
7. Bos PK, Kops N, Verhaar JAN, van Osch GJVM. Cellular origin of neocartilage formed at wound edges of articular cartilage in a tissue culture experiment.Osteoarthritis Cartilage.2008;16(2):204–211.
8.
8. Brighton CT, Shadle CA, Jimenez SA, Irwin JT, Lane JM, Lipton M. Articular cartilage preservation and storage: I. Application of tissue culture techniques to the storage of viable articular cartilage.Arthritis Rheum.1979;22(10):1093–1101.
12. Convery FR, Akeson WH, Amiel D, Meyers MH, Monosov A. Long-term survival of chondrocytes in an osteochondral articular cartilage allograft: a case report.J Bone Joint Surg Am.1996;78: 1082–1088.
13.
13. Convery FR, Meyers MH, Akeson WH. Fresh osteochondral allografting of the femoral condyle.Clin Orthop Relat Res.1991;273:139–145.
14.
14. Csonge L, Bravo D, Newman-Gage H, et al. Banking of osteochon-dral allografts: part II, preservation of chondrocyte viability during long-term storage.Cell Tissue Bank.2002;3:161–168.
15.
15. Czitrom AA, Keating S, Gross AE. The viability of articular cartilage in fresh osteochondral allografts after clinical transplantation.J Bone Joint Surg Am.1990;72:574–581.
16.
16. Dontchos BN, Coyle CH, Izzo NJ, et al. Optimizing CO2 normalizes pH and enhances chondrocyte viability during cold storage.J Orthop Res.2008;26(5):643–650.
17.
17. Dumont J, Ionescu M, Reiner A, et al. Mature full-thickness articular cartilage explants attached to bone are physiologically stable over long-term culture in serum-free media.Connect Tissue Res.1999;40(4):259–272.
18.
18. Emmerson BC, Gortz S, Jamali AA, Chung C, Amiel D, Bugbee WD. Fresh osteochondral allografting in the treatment of osteochondritis dissecans of the femoral condyle.Am J Sports Med.2007;35(6): 907–914.
19.
19. Enneking WF, Campanacci DA. Retrieved human allografts: a clinico-pathological study.J Bone Joint Surg Am.2001;83(7):971–986.
20.
20. Enneking WF, Mindell ER. Observations on massive retrieved human allografts.J Bone Joint Surg Am.1991;73:1123–1142.
21.
21. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.Connect Tissue Res.1982;9:247–248.
22.
22. Garrett JC. Fresh osteochondral allografts for treatment of articular defects in osteochondritis dissecans of the lateral femoral condyle in adults.Clin Orthop Relat Res.1994;303:33–37.
23.
23. Gonzalez RC, Woods RE, Eddins SL. Digital Image Processing Using MATLAB.Upper Saddle River, N J: Pearson Prentice Hall; 2004.
24.
24. Gortz S, Bugbee WD. Allografts in articular cartilage repair.J Bone Joint Surg Am.2006;88(6):1374–1384.
26. Guidance for industry: screening and testing of human tissue intended for transplantation. Washington, DC: US Department of Health & Human Services: Food and Drug Administration Center for Biologics Evaluation and Research; 2002. Available at www.fda.gov/cber/tiss.htm. Accessed May 14, 2009.
28. Hascall VC, Handley CJ, McQuillan DJ, Hascall GK, Robinson HC, Lowther DA. The effect of serum on biosynthesis of proteoglycans by bovine articular cartilage in culture.Arch Biochem Biophys.1983;224:206–223.
29.
29. Herbage D, Bouillet J, Bernengo J-C. Biochemical and physicochem-ical characterization of pepsin-solubilized type-II collagen from bovine articular cartilage.Biochem J.1977;161:303–312.
30.
30. Jamali AA, Hatcher SL, You Z. Donor cell survival in a fresh osteo-chondral allograft at twenty-nine years: a case report.J Bone Joint Surg Am.2007;89:166–169.
31.
31. Jay GD, Torres JR, Rhee DK, et al. Association between friction and wear in diarthrodial joints lacking lubricin.Arthritis Rheum.2007;56(11):3662–3669.
32.
32. Korver GHV, van de Stadt RJ, van Kampen GPJ, Kiljan E, van der Korst JK. Bovine sesamoid bones: a culture system for anatomically intact articular cartilage.In Vitro Cell Dev Biol.1989;25: 1099–1106.
33.
33. LaPrade RF, Botker J, Herzog M, Agel J. Refrigerated osteoarticular allografts to treat articular cartilage defects of the femoral condyles: a prospective outcomes study.J Bone Joint Surg Am.2009;91(4): 805–811.
34.
34. Lattermann C, Romine SE. Osteochondral allografts: state of the art.Clin Sports Med.2009;28(2):285–301, ix.
35.
35. Lexer E. Joint transplantation.Clin Orthop Relat Res.1985;197: 4–10.
37. Mankin HJ, Doppelt S, Tomford W. Clinical experience with allograft implantation: the first ten years.Clin Orthop Relat Res.1983;174: 69–86.
38.
38. Mankin HJ, Gebhardt MC, Tomford WW. The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities.Orthop Clin North Am.1987;18(2):275–289.
39.
39. Maury AC, Safir O, Heras FL, Pritzker KP, Gross AE. Twenty-five-year chondrocyte viability in fresh osteochondral allograft: a case report.J Bone Joint Surg Am.2007;89:159–165.
40.
40. McCulloch PC, Kang RW, Sobhy MH, Hayden JK, Cole BJ. Prospective evaluation of prolonged fresh osteochondral allograft transplantation of the femoral condyle: minimum 2-year follow-up.Am J Sports Med.2007;35:411–420.
41.
41. McDermott AG, Langer F, Pritzker KP, Gross AE. Fresh small-fragment osteochondral allografts: long-term follow-up study on first 100 cases.Clin Orthop Relat Res.1985;197:96–102.
42.
42. McGoveran BM, Pritzker KP, Shasha N, Price J, Gross AE. Long-term chondrocyte viability in a fresh osteochondral allograft.J Knee Surg.2002;15(2):97–100.
43.
43. Morales TI, Hascall VC. Factors involved in the regulation of proteogly-can metabolism in articular cartilage.Arthritis Rheum.1989;32: 1197–1201.
44.
44. Pal S, Tang L-H, Choi H, et al. Structural changes during development in bovine fetal epiphyseal cartilage.Collagen Relat Res.1981;1:151–176.
45.
45. Papadopoulos NG, Dedoussis GV, Spanakos G, Gritzapis AD, Baxe-vanis CN, Papamichail M. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.J Immunol Methods.1994;177(1-2):101–111.
46.
46. Pearsall AW, Tucker JA, Hester RB, Heitman RJ. Chondrocyte viability in refrigerated osteochondral allografts used for transplantation within the knee.Am J Sports Med.2004;32(1):125–131.
47.
47. Pennock AT, Robertson CM, Wagner F, Harwood FL, Bugbee WD, Amiel D. Does subchondral bone affect the fate of osteochondral allografts during storage?Am J Sports Med.2006;34(4):586–591.
48.
48. Pennock AT, Wagner F, Robertson CM, Harwood FL, Bugbee WD, Amiel D. Prolonged storage of osteochondral allografts: does the addition of fetal bovine serum improve chondrocyte viability?J Knee Surg.2006;19(4):265–272.
49.
49. Sah RL, Trippel SB, Grodzinsky AJ. Differential effects of serum, insulin-like growth factor-I, and fibroblast growth factor-2 on the maintenance of cartilage physical properties during long-term culture.J Orthop Res.1996;14:44–52.
50.
50. Schmidt TA, Gastelum NS, Nguyen QT, Schumacher BL, Sah RL. Boundary lubrication of articular cartilage: role of synovial fluid constituents.Arthritis Rheum.2007;56:882–891.
51.
51. Schumacher BL, Hughes CE, Kuettner KE, Caterson B, Aydelotte MB. Immunodetection and partial cDNA sequence of the proteogly-can, superficial zone protein, synthesized by cells lining synovial joints.J Orthop Res.1999;17:110–120.
53. Teng MS, Yuen AS, Kim HT. Enhancing osteochondral allograft viability: effects of storage media composition.Clin Orthop Relat Res.2008;466(8):1804–1809.
54.
54. Von den Hoff HW, de Koning MH, van Kampen GP, van der Korst JK. Transforming growth factor-beta stimulates retinoic acid-induced proteoglycan depletion in intact articular cartilage.Arch Biochem Biophys.1994;313(2):241–247.
55.
55. von den Hoff JW, van Kampen GPJ, van de Stadt RJ, van der Korst JK. Kinetics of proteoglycan turnover in bovine articular cartilage explants.Matrix.1993;13:195–201.
56.
56. Weston SA, Parish CR. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy.J Immunol Methods.1990;133(1):87–97.
57.
57. Williams JM, Virdi AS, Pylawka TK, Edwards RB 3rd, Markel MD, Cole BJ. Prolonged-fresh preservation of intact whole canine femoral condyles for the potential use as osteochondral allografts.J Orthop Res.2005;23(4):831–837.
58.
58. Williams RJ 3rd, Dreese JC, Chen CT. Chondrocyte survival and material properties of hypothermically stored cartilage: an evaluation of tissue used for osteochondral allograft transplantation.Am J Sports Med.2004;32(1):132–139.
59.
59. Williams RJ 3rd, Ranawat AS, Potter HG, Carter T, Warren RF. Fresh stored allografts for the treatment of osteochondral defects of the knee.J Bone Joint Surg Am.2007;89:718–726.
60.
60. Williams SK, Amiel D, Ball ST, et al. Analysis of cartilage tissue on a cellular level in fresh osteochondral allograft retrievals.Am J Sports Med.2007;35:2022–2032.
61.
61. Williams SK, Amiel D, Ball ST, et al. Prolonged storage effects on the articular cartilage of fresh human osteochondral allografts.J Bone Joint Surg Am.2003;85:2111–2120.
62.
62. Williamson AK, Masuda K, Thonar EJ-MA, Sah RL. Growth of immature articular cartilage in vitro: correlated variation in tensile biome-chanical and collagen network properties.Tissue Eng.2003;9: 625–634.
63.
63. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.Arch Biochem Biophys.1961;93:440–447.
